001     111906
005     20200402210033.0
024 7 _ |2 pmid
|a pmid:22045336
024 7 _ |2 pmc
|a pmc:PMC3273382
024 7 _ |2 DOI
|a 10.1038/emboj.2011.366
024 7 _ |2 WOS
|a WOS:000300871700019
024 7 _ |a altmetric:21819279
|2 altmetric
037 _ _ |a PreJuSER-111906
041 _ _ |a eng
082 _ _ |a 570
100 1 _ |0 P:(DE-HGF)0
|a Cong, Y
|b 0
245 _ _ |a Symmetry-Free Cryo-EM Structures of the Chaperonin TRiC Along its ATPase-Driven Conformational Cycle
260 _ _ |a London [u.a.]
|b Nature Publishing Group
|c 2011
300 _ _ |a 720 - 730
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |0 1793
|a Embo Journal
|v 31
|x 0261-4189
|y 3
500 _ _ |3 POF3_Assignment on 2016-02-29
500 _ _ |a Record converted from VDB: 16.11.2012
520 _ _ |a The eukaryotic group II chaperonin TRiC/CCT is a 16-subunit complex with eight distinct but similar subunits arranged in two stacked rings. Substrate folding inside the central chamber is triggered by ATP hydrolysis. We present five cryo-EM structures of TRiC in apo and nucleotide-induced states without imposing symmetry during the 3D reconstruction. These structures reveal the intra- and inter-ring subunit interaction pattern changes during the ATPase cycle. In the apo state, the subunit arrangement in each ring is highly asymmetric, whereas all nucleotide-containing states tend to be more symmetrical. We identify and structurally characterize an one-ring closed intermediate induced by ATP hydrolysis wherein the closed TRiC ring exhibits an observable chamber expansion. This likely represents the physiological substrate folding state. Our structural results suggest mechanisms for inter-ring-negative cooperativity, intra-ring-positive cooperativity, and protein-folding chamber closure of TRiC. Intriguingly, these mechanisms are different from other group I and II chaperonins despite their similar architecture.
536 _ _ |0 G:(DE-Juel1)FUEK409
|2 G:(DE-HGF)
|a Funktion und Dysfunktion des Nervensystems
|c P33
|x 0
536 _ _ |0 G:(DE-Juel1)FUEK505
|a BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung
|c P45
|x 1
588 _ _ |a Dataset connected to Pubmed
650 _ 2 |2 MeSH
|a Adenosine Triphosphatases: metabolism
650 _ 2 |2 MeSH
|a Chaperonins: chemistry
650 _ 2 |2 MeSH
|a Chaperonins: metabolism
650 _ 2 |2 MeSH
|a Cryoelectron Microscopy
650 _ 2 |2 MeSH
|a Hydrolysis
650 _ 2 |2 MeSH
|a Models, Molecular
650 _ 2 |2 MeSH
|a Protein Conformation
650 _ 2 |2 MeSH
|a Protein Folding
650 _ 7 |0 EC 3.6.1.-
|2 NLM Chemicals
|a Adenosine Triphosphatases
650 _ 7 |0 EC 3.6.1.-
|2 NLM Chemicals
|a Chaperonins
700 1 _ |0 P:(DE-Juel1)132018
|a Schröder, G.F.
|b 1
|u FZJ
700 1 _ |0 P:(DE-HGF)0
|a Meyer, A.S.
|b 2
700 1 _ |0 P:(DE-HGF)0
|a Jakana, J.
|b 3
700 1 _ |0 P:(DE-HGF)0
|a Ma, B.
|b 4
700 1 _ |0 P:(DE-HGF)0
|a Dougherty, M.T.
|b 5
700 1 _ |0 P:(DE-HGF)0
|a Schmid, M.F.
|b 6
700 1 _ |0 P:(DE-HGF)0
|a Reissmann, S.
|b 7
700 1 _ |0 P:(DE-HGF)0
|a Levitt, M.
|b 8
700 1 _ |0 P:(DE-HGF)0
|a Ludtke, S.L.
|b 9
700 1 _ |0 P:(DE-HGF)0
|a Frydman, J.
|b 10
700 1 _ |0 P:(DE-HGF)0
|a Chiu, W.
|b 11
773 _ _ |0 PERI:(DE-600)1467419-1
|a 10.1038/emboj.2011.366
|g Vol. 31, p. 720 - 730
|p 720 - 730
|q 31<720 - 730
|t The @EMBO journal online
|v 31
|x 0261-4189
|y 2011
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273382
909 C O |o oai:juser.fz-juelich.de:111906
|p VDB
913 1 _ |0 G:(DE-Juel1)FUEK409
|1 G:(DE-HGF)POF2-330
|2 G:(DE-HGF)POF2-300
|b Gesundheit
|k P33
|l Funktion und Dysfunktion des Nervensystems
|v Funktion und Dysfunktion des Nervensystems
|x 0
913 1 _ |0 G:(DE-Juel1)FUEK505
|1 G:(DE-HGF)POF2-450
|2 G:(DE-HGF)POF2-400
|b Schlüsseltechnologien
|k P45
|l Biologische Informationsverarbeitung
|v BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung
|x 1
913 2 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-559H
|2 G:(DE-HGF)POF3-500
|v Addenda
|x 0
914 1 _ |y 2012
915 _ _ |a JCR/ISI refereed
|0 StatID:(DE-HGF)0010
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|g ICS
|k ICS-6
|l Strukturbiochemie
|x 0
970 _ _ |a VDB:(DE-Juel1)140537
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-7-20200312


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21